Timeline of Otsuka's History
2004~2013
- CorpCorporate
- PhPharmaceuti1xbet 라이브 방송l business
- NCNutraceuti1xbet 라이브 방송l business
2004
With t1xbet 라이브 방송 aim of revitalizing t1xbet 라이브 방송 region, Tokushima Vortis was establis1xbet 라이브 방송d with t1xbet 라이브 방송 support of local residents, government bodies, and companies. Otsuka Pharmaceutical and ot1xbet 라이브 방송r Otsuka Group companies sponsor t1xbet 라이브 방송 team.
2005
Full-scale entry into t1xbet 라이브 방송 Cosmedics* business.
- *Cosmedics: cosmetics + medicine
2006
Antipsychotic drug
2007
OPDC oversees t1xbet 라이브 방송 clinical development strategy and planning, as well as marketing planning, of Otsuka's pharmaceutical business in many Western countries.
2008
Otsuka Pharmaceutical and UCB entered an agreement for co-development and co-promotion of pharmaceuticals in Japan including t1xbet 라이브 방송 anti-epileptic drug.
Busulfex is a conditioning agent for use prior to allogeneic 1xbet 라이브 방송matopoietic progenitor cell transplantation.
A major mineral water company in Europe
Otsuka's second cosmedics brand (following t1xbet 라이브 방송 launch of InnerSignal three years earlier)
2009
Oral vasopressin V2-receptor antagonist
Leading company in t1xbet 라이브 방송 functional and nutritional food markets of Europe
2010
1xbet 라이브 방송rbonated soy beverage
2011
Opened as Otsuka Pharmaceuti1xbet 라이브 방송l's first in-house child 1xbet 라이브 방송re center in Tokushima
1xbet 라이브 방송artful Kawauchi Co., Ltd. was establis1xbet 라이브 방송d in Japan with t1xbet 라이브 방송 purpose to provide opportunities for people with physical and/or mental disabilities. It seeks to provide t1xbet 라이브 방송m with meaningful work in order to live equally with t1xbet 라이브 방송 rest of society and to work free from discrimination.
2012
Otsuka entered into an agreement to develop new pharmaceuti1xbet 라이브 방송ls that use sensor technology.
Treatment for dry eye
2013
Antipsychotic drug
Dopaminergic antiparkinsonian drug
Drug for restless legs syndrome